Alveo Technologies

At Alveo, were on a mission to use our open, accessible, and actionable molecular detection platform to detect pathogens before they spread. Our portable, handheld, analyzer and cloud-based data analytics brings molecular detection out of the lab and into the field. Alveos agile platform can be adapted to detect a wide range pathogens including viruses, bacteria, and fungi. Whether testing a patient at a pharmacy at the point-of-care, chickens pen-side at the point-of-need, or farmers testing crops in-the-field, Alveos technology brings users real time data precisely when and where it matters most. Partner with Alveo today to bring the power...

Health tech,portable diagnostics,assay development,microfluidics,infectious disease detection,disruptive technology,start-up,manufacturing,engineering,partners,open platform,molecular diagnostics,and pathogen detection

Alveo technologies operates in the Biotechnology research industry.

Alveo technologies's revenue is 11m - 100m

Alveo technologies has 51 - 200 employees.